OMEZ 40 + OMEZ 80

ApprovedCompleted
0 views this week 0 watching Active
Interest: 40/100
40
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
Phase 3
5
Approved
Indication / Disease

GERD

Conditions

GERD

Trial Timeline

Jan 1, 2013 → Jun 1, 2013

About OMEZ 40 + OMEZ 80

OMEZ 40 + OMEZ 80 is a approved stage product being developed by Dr. Reddy's Laboratories for GERD. The current trial status is completed. This product is registered under clinical trial identifier NCT02922699. Target conditions include GERD.

What happened to similar drugs?

11 of 20 similar drugs in GERD were approved

Approved (11) Terminated (0) Active (9)
omeprazole+domperidone SR + omeprazoleDr. Reddy's LaboratoriesApproved
EsomeprazoleAstraZenecaApproved
EsomeprazoleAstraZenecaApproved
EsomeprazoleAstraZenecaApproved
Esomeprazole (Nexium)AstraZenecaApproved
EsomeprazoleAstraZenecaApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT02922699ApprovedCompleted

Competing Products

20 competing products in GERD

See all competitors
ProductCompanyStageHype Score
omeprazole+domperidone SR + omeprazoleDr. Reddy's LaboratoriesApproved
36
Rabeprazole ER + RanitidineEisaiPhase 3
40
Rabeprazole sodiumEisaiPhase 1
29
Rabeprazole sodium + EsomeprazoleEisaiPhase 3
40
rabeprazole sodium + PlaceboEisaiPhase 3
40
Rabeprazole ER + RanitidineEisaiPhase 3
40
Rabeprazole sodium 5 mg + Rabeprazole sodium 10 mgEisaiPhase 1
29
rabeprazole + rabeprazoleEisaiPhase 3
40
Rabeprazole sodium + EsomeprazoleEisaiPhase 3
40
Rabeprazole sodium + EsomeprazoleEisaiPhase 3
40
ONO-8539Ono PharmaceuticalPhase 1
29
esomeprazole 40 mgJohnson & JohnsonPre-clinical
26
esomeprazole (Nexium®) + Xolaam®AstraZenecaApproved
43
esomeprazoleAstraZenecaPre-clinical
26
EsomeprazoleAstraZenecaApproved
43
EsomeprazoleAstraZenecaApproved
43
esomeprazole magnesiumAstraZenecaPhase 1
29
EsomeprazoleAstraZenecaApproved
43
EsomeprazoleAstraZenecaPhase 3
40
Esomeprazole (Nexium)AstraZenecaApproved
43